期刊文献+

Von-Hippel-Lindau病并发肾癌2例

Von Hippel-Lindau disease complicated with renal carcinoma: a report of 2 cases
原文传递
导出
摘要 目的探讨Von-Hippel-Lindau(VHL)病并发肾癌等疾病的临床特点。方法回顾分析山东大学第二医院收治的2例VHL病并发肾癌的患者,并结合文献复习。结果 2例中1例有家族史,行右肾癌根治术,病理显示为肾透明细胞癌,术后随访1年,未见复发;1例无相关疾病家族史,先行右肾癌根治术,病理显示右肾多房性囊性肾细胞癌,右肾上腺嗜铬细胞瘤,术后4年左肾及左侧肾上腺出现肿瘤复发,左肾肿瘤穿刺病理提示肾透明细胞癌,给予分子靶向药物索拉菲尼治疗,现规律透析。结论 VHL病是涉及多个系统的肿瘤综合征,临床较为少见,其并发肾癌的特征不同于散发性肾癌;早诊断、早进行个体化治疗可改善患者晚期生存质量。 Objective To explore the clinical characteristics of Von Hippel-Lindau( VHL) disease complicated with renal carcinoma,in order to find better methods of diagnosis and treatment. Methods Clinical data of 2 cases of VHL disease complicated with renal carcinoma were retrospectively analyzed and relevant literature was reviewed. Results One of the 2 patients had family history and underwent right radical nephrectomy. Pathological examination suggested clear-cell carcinoma. No recurrence was found in this patient after one-year follow-up. The other patient did not have family history. He also underwent right radical nephrectomy. Pathological examination suggested multilocular cystic renal cell carcinoma in the right kidney and pheochromocytoma in the right adrenal gland. Four years later,carcinoma was found in the left kidney and left adrenal gland. Pathological examination of biopsy tissue in the left kidney tumor indicated clear-cell carcinoma. He received sorafenib,a molecular targeted drug,and regular hemodialysis. Conclusion VHL disease is a rare cancer syndrome that involves multiple systems. The characteristics of renal cancer concurrent with VHL are different from sporadic one. Early diagnosis and individualized treatment can improve the quality of patients' life. Newtreatments should be further explored.
出处 《山东大学学报(医学版)》 CAS 北大核心 2016年第2期86-89,94,共5页 Journal of Shandong University:Health Sciences
基金 山东省科技发展计划(2014GSF118150)
关键词 Von-Hippel-Lindau病 肾细胞肿瘤 家族性遗传病 临床特征 Von Hippel-Lindau disease Renal tumor Familial hereditary disease Clinical characteristics
作者简介 通讯作者:王绍勇。E—mail:wsy198606@sina.COm
  • 相关文献

参考文献17

  • 1Hayden MG, Gephart R, Kalanithi P, et al. Von Hippel- Lindau disease in pregnancy: a brief review [ J ]. J Clin Neurosci, 2009, 16(5): 611-613.
  • 2Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, et al. Genetic analysis of yon Hippel-Lindau disease [ J ]. Human mutation, 2010, 31 (5) : 521-537.
  • 3Sharma P, Dhull VS, Bal C, et al. Von Hippel-Lindau syndrome: demonstration of entire disease spectrum with (68) Ga-DOTANOC PET-CT[J ]. Korean J Radiol, 2014, 15(1) :169-172.
  • 4Neumann HP, Bender BU, Berger DP, et al. Prevalence morphology and biology of renal cell carcinoma in Von Hippel-Lindau disease compared to sporadicrenal cell car- cinoma[J]. J Urol, 1998, 160(4): 1248-1254.
  • 5Duffey BG, Choyke PL, Glenn G, et al. The relationship between renal tumor size and metastases in patients with yon Hippel-Lindau disease [ J]. J Urol, 2004, 172 ( 1 ) : 63 -65.
  • 6Gupta GN, Peterson J, Thakore KN, et al. Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm[ J]. J Urol, 2010, 184( 1 ) : 59-63.
  • 7Patard JJ. European Association of Urology Guidelines for systemic therapy in metastatic renal cell carcinoma: what is recommended and why?[ J ]. European Urology Sup- plements, 2008, 7 (2) : 46-54.
  • 8赵欣,徐维锋,李汉忠.Von Hippel-Lindau病特点分析及外科处理[J].癌症进展,2012,10(4):419-424. 被引量:4
  • 9Jimenez C, Cabanillas ME, Santarpia L, et al. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other Von Hippel-Lindau disease- related tumors [ J ]. J Clin Endocrinol Metal), 2009, 94 (2) : 386-391.
  • 10Ibfiez de Ciceres I, Cairns P. Methylated DNA se- quences for early cancer detection, molecular classifica- tion and chemotherapy response prediction [ J ]. Clin Transl Oncol, 2007, 9(7) : 429-437.

二级参考文献21

  • 1Nordstrom-O'Brien M,van der Luijt RB,van Rooijen E,et al.Genetic analysis of von Hippel-Lindau disease[J].Hum Mutat,2010,31(5):521-537.
  • 2Richard S,Graff J,Lindau J,et al.Von Hippel-Lindau disease[J].Lancet,2004,363(9416):1231-1234.
  • 3Neumann HP,Zbar B.Renal cysts,renal cancer and von Hippel-Lindau disease[J].Kidney Int,1997,51(1):16-26.
  • 4Latif F,Tory K,Gnarra J,et al.Identification of the von Hippel-Lindau disease tumor suppressor gene[J].Science,1993,260(5112):1317-1320.
  • 5Melmon KS,Rosen SW.Lindau's disease.Review of the literature and study of a large kindred[J].Am J Med,1964,36:595-617.
  • 6Kaelin WG Jr.Treatment of kidney cancer:insights provided by the VHL tumor-suppressor protein[J].Cancer,2009,115(10 Suppl):2262-2272.
  • 7Maxwell PH,Wiesener MS,Chang GW,et al.The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis[J].Nature,1999,399(6733):271-275.
  • 8Kamura T,Koepp DM,Conrad MN,et al.Rbx1,a component of the VHL tumor suppressor complex and SCF ubiquitin ligase[J].Science,1999,284(5414):657-661.
  • 9Ivan M,Kondo K,Yang H,et al.HIF-alpha targeted for VHL-mediated destruction by proline hydroxylation:implications for O2 sensing[J].Science,2001,292(5516):464-468.
  • 10Jaakkola P,Mole DR,Tian YM,et al.Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation[J].Science,2001,292(5516):468-472.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部